416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis

Details 詳細情報について

• CRID

  1362262945810706688

• DOI

  10.1016/s0016-5085(19)36989-6

• ISSN

  00165085

• Web Site

  https://api.elsevier.com/content/article/PII:S0016508519369896?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0016508519369896?httpAccept=text/plain

• Data Source

  • Crossref